drugset / Trial / NCT02644590

The Effect of Melatonin on Early Signs of Hypertension in Teenagers With Diabetes Mellitus Type 1

NCT02644590

Phase 0 Unknown 30 enrolled Sheba Medical Center
NaSingle-groupOpen-labelTreatment

Summary

Nocturnal hypertension is recognized via ambulatory blood pressure monitoring in adolescents with type 1 diabetes mellitus. Melatonin, (as previously seen in earlier studies in adults), may alter these changes, which may be a benefit especially for patients with diabetes mellitus who are at risk for cardiovascular changes. The purpose of this study is to estimate the use of melatonin as treatment for nocturnal hypertension in young adults with type 1 diabetes melitus.

Timeline

Start
2016-02
Primary completion
2016-09
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 2 mg